{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T15:27:51Z","timestamp":1789918071759,"version":"4.0.1"},"reference-count":173,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.00780","type":"journal-article","created":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T23:58:19Z","timestamp":1499126299000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Antiviral Functions of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific IgG Antibodies: Effects of Antiretroviral Therapy and Implications for Therapeutic HIV-1 Vaccine Design"],"prefix":"10.3389","volume":"8","author":[{"given":"Martyn A.","family":"French","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Christian","family":"Tjiam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila N.","family":"Abudulai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,7,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nm1520","article-title":"CD8+ T-cell responses to different HIV proteins have discordant associations with viral load","volume":"13","author":"Kiepiela","year":"2007","journal-title":"Nat Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1128\/JVI.80.7.3617-3623.2006","article-title":"Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1","volume":"80","author":"Martinez-Picado","year":"2006","journal-title":"J Virol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.immuni.2015.08.012","article-title":"Magnitude and kinetics of CD8+ T cell activation during hyperacute HIV infection impact viral set point","volume":"43","author":"Ndhlovu","year":"2015","journal-title":"Immunity"},{"key":"B4","doi-asserted-by":"publisher","first-page":"6776","DOI":"10.1073\/pnas.0611244104","article-title":"HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype","volume":"104","author":"Saez-Cirion","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"Buchbinder","year":"2008","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1056\/NEJMoa1310566","article-title":"Efficacy trial of a DNA\/rAd5 HIV-1 preventive vaccine","volume":"369","author":"Hammer","year":"2013","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nature18929","article-title":"HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption","volume":"535","author":"Scheid","year":"2016","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"319ra206","DOI":"10.1126\/scitranslmed.aad5752","article-title":"Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection","volume":"7","author":"Lynch","year":"2015","journal-title":"Sci Transl Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nature14411","article-title":"Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117","volume":"522","author":"Caskey","year":"2015","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1126\/science.aaf1279","article-title":"Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo","volume":"352","author":"Lu","year":"2016","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1126\/science.aaf0972","article-title":"HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1","volume":"352","author":"Schoofs","year":"2016","journal-title":"Science"},{"key":"B12","doi-asserted-by":"publisher","first-page":"6276","DOI":"10.1128\/JVI.00557-16","article-title":"Biphasic CD8+ T-cell defense in simian immunodeficiency virus control by acute-phase passive neutralizing antibody immunization","volume":"90","author":"Iseda","year":"2016","journal-title":"J Virol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11904-016-0299-7","article-title":"Broadly neutralizing antibodies for HIV eradication","volume":"13","author":"Stephenson","year":"2016","journal-title":"Curr HIV\/AIDS Rep"},{"key":"B14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1172\/JCI80561","article-title":"Towards HIV-1 remission: potential roles for broadly neutralizing antibodies","volume":"126","author":"Halper-Stromberg","year":"2016","journal-title":"J Clin Invest"},{"key":"B15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/COH.0000000000000153","article-title":"HIV broadly neutralizing antibody targets","volume":"10","author":"Wibmer","year":"2015","journal-title":"Curr Opin HIV AIDS"},{"key":"B16","doi-asserted-by":"publisher","first-page":"157895","DOI":"10.1155\/2014\/157895","article-title":"Neutralization of virus infectivity by antibodies: old problems in new perspectives","volume":"2014","author":"Klasse","year":"2014","journal-title":"Adv Biol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e1005315","DOI":"10.1371\/journal.ppat.1005315","article-title":"Polyfunctional HIV-specific antibody responses are associated with spontaneous HIV control","volume":"12","author":"Ackerman","year":"2016","journal-title":"PLoS Pathog"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1097\/QAD.0000000000001242","article-title":"Control of early HIV-1 infection associates with plasmacytoid dendritic cell-reactive opsonophagocytic IgG antibodies to HIV-1 p24","volume":"30","author":"Tjiam","year":"2016","journal-title":"AIDS"},{"key":"B19","doi-asserted-by":"publisher","first-page":"5320","DOI":"10.4049\/jimmunol.1402918","article-title":"Viremic HIV controllers exhibit high plasmacytoid dendritic cell-reactive opsonophagocytic IgG antibody responses against HIV-1 p24 associated with greater antibody isotype diversification","volume":"194","author":"Tjiam","year":"2015","journal-title":"J Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/imr.12331","article-title":"The multiple facets of FcRn in immunity","volume":"268","author":"Stapleton","year":"2015","journal-title":"Immunol Rev"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1097\/QAD.0000000000001038","article-title":"Broadly neutralizing antibody specificities detected in the genital tract of HIV-1 infected women","volume":"30","author":"Mkhize","year":"2016","journal-title":"AIDS"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1016\/j.jaci.2014.03.032","article-title":"Plasmacytoid dendritic cell depletion in DOCK8 deficiency: rescue of severe herpetic infections with IFN-alpha 2b therapy","volume":"133","author":"Keles","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.clim.2015.11.004","article-title":"Natural killer cell biology illuminated by primary immunodeficiency syndromes in humans","volume":"177","author":"Voss","year":"2015","journal-title":"Clin Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/ACI.0000000000000322","article-title":"Dendritic cell analysis in primary immunodeficiency","volume":"16","author":"Bigley","year":"2016","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1742-4690-8-16","article-title":"Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infection","volume":"8","author":"Willey","year":"2011","journal-title":"Retrovirology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1126\/science.aad3439","article-title":"Visualizing antibody affinity maturation in germinal centers","volume":"351","author":"Tas","year":"2016","journal-title":"Science"},{"key":"B27","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3389\/fimmu.2016.00225","article-title":"How follicular dendritic cells shape the B-cell antigenome","volume":"7","author":"Kranich","year":"2016","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"298ra120","DOI":"10.1126\/scitranslmed.aab3964","article-title":"Quality and quantity of TFH cells are critical for broad antibody development in SHIVAD8 infection","volume":"7","author":"Yamamoto","year":"2015","journal-title":"Sci Transl Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.immuni.2010.07.015","article-title":"Follicular helper T cell differentiation requires continuous antigen presentation that is independent of unique B cell signaling","volume":"33","author":"Deenick","year":"2010","journal-title":"Immunity"},{"key":"B30","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.immuni.2012.11.020","article-title":"Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype","volume":"38","author":"Baumjohann","year":"2013","journal-title":"Immunity"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0065-2776(06)93001-6","article-title":"Class switch recombination: a comparison between mouse and human","volume":"93","author":"Pan-Hammarstrom","year":"2007","journal-title":"Adv Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/icb.2014.44","article-title":"Human immunoglobulin classes and subclasses show variability in VDJ gene mutation levels","volume":"92","author":"Jackson","year":"2014","journal-title":"Immunol Cell Biol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/icb.2014.48","article-title":"B cells take their time: sequential IgG class switching over the course of an immune response?","volume":"92","author":"van Zelm","year":"2014","journal-title":"Immunol Cell Biol"},{"key":"B34","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0021-9258(19)75181-3","article-title":"Primary structure of the \u201chinge\u201d region of human IgG3. Probable quadruplication of a 15-amino acid residue basic unit","volume":"252","author":"Michaelsen","year":"1977","journal-title":"J Biol Chem"},{"key":"B35","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1365-3083.1994.tb03416.x","article-title":"Opsonophagocytic activity induced by chimeric antibodies of the four human IgG subclasses with or without help from complement","volume":"39","author":"Aase","year":"1994","journal-title":"Scand J Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1046\/j.0019-2805.2001.01341.x","article-title":"IgG4 breaking the rules","volume":"105","author":"Aalberse","year":"2002","journal-title":"Immunology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ccell.2014.11.001","article-title":"Conformation of the human immunoglobulin G2 hinge imparts superagonistic properties to immunostimulatory anticancer antibodies","volume":"27","author":"White","year":"2015","journal-title":"Cancer Cell"},{"key":"B38","doi-asserted-by":"publisher","first-page":"16194","DOI":"10.1074\/jbc.M709987200","article-title":"Human IgG2 antibodies display disulfide-mediated structural isoforms","volume":"283","author":"Wypych","year":"2008","journal-title":"J Biol Chem"},{"key":"B39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/imr.12350","article-title":"Mouse and human FcR effector functions","volume":"268","author":"Bruhns","year":"2015","journal-title":"Immunol Rev"},{"key":"B40","doi-asserted-by":"publisher","first-page":"4951","DOI":"10.4049\/jimmunol.1201294","article-title":"Specific serum Ig recognizing staphylococcal wall teichoic acid induces complement-mediated opsonophagocytosis against Staphylococcus aureus","volume":"189","author":"Jung","year":"2012","journal-title":"J Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.4049\/jimmunol.170.6.3134","article-title":"Human IgG2 can form covalent dimers","volume":"170","author":"Yoo","year":"2003","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1365-3083.1982.tb00750.x","article-title":"Cleavage of the four human IgG subclasses with cathepsin G","volume":"16","author":"Baici","year":"1982","journal-title":"Scand J Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","article-title":"Follicular helper CD4 T cells (TFH)","volume":"29","author":"Crotty","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nri3447","article-title":"The good, the bad and the ugly \u2013 TFH cells in human health and disease","volume":"13","author":"Tangye","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.it.2014.06.002","article-title":"Phenotype and functions of memory TFH cells in human blood","volume":"35","author":"Schmitt","year":"2014","journal-title":"Trends Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.4049\/jimmunol.1402316","article-title":"Granzyme B expression is enhanced in human monocytes by TLR8 agonists and contributes to antibody-dependent cellular cytotoxicity","volume":"194","author":"Elavazhagan","year":"2015","journal-title":"J Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/imr.12347","article-title":"bIgG time for large eaters: monocytes and macrophages as effector and target cells of antibody-mediated immune activation and repression","volume":"268","author":"Gordan","year":"2015","journal-title":"Immunol Rev"},{"key":"B48","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jim.2012.07.006","article-title":"Role of monocytes in mediating HIV-specific antibody-dependent cellular cytotoxicity","volume":"384","author":"Kramski","year":"2012","journal-title":"J Immunol Methods"},{"key":"B49","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1097\/QAD.0b013e32834507bd","article-title":"The broadly neutralizing HIV-1 IgG 2F5 elicits gp41-specific antibody-dependent cell cytotoxicity in a FcgammaRI-dependent manner","volume":"25","author":"Tudor","year":"2011","journal-title":"AIDS"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1097\/QAD.0b013e32834b64bd","article-title":"IgG2 inhibits HIV-1 internalization by monocytes, and IgG subclass binding is affected by gp120 glycosylation","volume":"25","author":"Forthal","year":"2011","journal-title":"AIDS"},{"key":"B51","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nri3582","article-title":"The function of Fcgamma receptors in dendritic cells and macrophages","volume":"14","author":"Guilliams","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1399-0039.2006.00585.x","article-title":"Cysteine cathepsins in the immune response","volume":"67","author":"Zavasnik-Bergant","year":"2006","journal-title":"Tissue Antigens"},{"key":"B53","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1365-2222.2009.03207.x","article-title":"Immunoglobulin G4: an odd antibody","volume":"39","author":"Aalberse","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"B54","doi-asserted-by":"publisher","first-page":"228ra38","DOI":"10.1126\/scitranslmed.3007736","article-title":"Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines","volume":"6","author":"Chung","year":"2014","journal-title":"Sci Transl Med"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1172\/JCI65708","article-title":"Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity","volume":"123","author":"Ackerman","year":"2013","journal-title":"J Clin Invest"},{"key":"B56","first-page":"134","article-title":"IgG subclasses in viral infections","volume":"19","author":"Skvaril","year":"1986","journal-title":"Monogr Allergy"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1086\/430320","article-title":"Combination of HIV-1-specific CD4 Th1\u2009cell responses and IgG2 antibodies is the best predictor for persistence of long-term nonprogression","volume":"191","author":"Martinez","year":"2005","journal-title":"J Infect Dis"},{"key":"B58","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/QAD.0b013e32835cb720","article-title":"Isotype-switched immunoglobulin G antibodies to HIV Gag proteins may provide alternative or additional immune responses to \u2019protective\u2019 human leukocyte antigen-B alleles in HIV controllers","volume":"27","author":"French","year":"2013","journal-title":"AIDS"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1097\/QAD.0b013e32833c1ce0","article-title":"Vaccine-induced IgG2 anti-HIV p24 is associated with control of HIV in patients with a \u2019high-affinity\u2019 FcgammaRIIa genotype","volume":"24","author":"French","year":"2010","journal-title":"AIDS"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1128\/JVI.03130-13","article-title":"Divergent antibody subclass and specificity profiles but not protective HLA-B alleles are associated with variable antibody effector function among HIV-1 controllers","volume":"88","author":"Lai","year":"2014","journal-title":"J Virol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature06106","article-title":"Fc receptor but not complement binding is important in antibody protection against HIV","volume":"449","author":"Hessell","year":"2007","journal-title":"Nature"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.cell.2014.08.023","article-title":"Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity","volume":"158","author":"Bournazos","year":"2014","journal-title":"Cell"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/mi.2016.12","article-title":"Fc receptor-mediated phagocytosis in tissues as a potent mechanism for preventive and therapeutic HIV vaccine strategies","volume":"9","author":"Sips","year":"2016","journal-title":"Mucosal Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e85371","DOI":"10.1371\/journal.pone.0085371","article-title":"HIV-1 specific antibody titers and neutralization among chronically infected patients on long-term suppressive antiretroviral therapy (ART): a cross-sectional study","volume":"9","author":"Gach","year":"2014","journal-title":"PLoS One"},{"key":"B65","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.4049\/jimmunol.166.5.3266","article-title":"MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells","volume":"166","author":"Zhu","year":"2001","journal-title":"J Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1182\/blood-2006-05-024539","article-title":"FcRn: an IgG receptor on phagocytes with a novel role in phagocytosis","volume":"108","author":"Vidarsson","year":"2006","journal-title":"Blood"},{"key":"B67","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1128\/CVI.13.2.165-169.2006","article-title":"Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines","volume":"13","author":"Romero-Steiner","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"5163","DOI":"10.1182\/blood-2012-06-434498","article-title":"Fcgamma receptor antigen targeting potentiates cross-presentation by human blood and lymphoid tissue BDCA-3+ dendritic cells","volume":"120","author":"Flinsenberg","year":"2012","journal-title":"Blood"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.4049\/jimmunol.1303126","article-title":"Antibody-opsonized bacteria evoke an inflammatory dendritic cell phenotype and polyfunctional Th cells by cross-talk between TLRs and FcRs","volume":"194","author":"Bakema","year":"2015","journal-title":"J Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1182\/blood-2011-12-399931","article-title":"IgG opsonization of bacteria promotes Th17 responses via synergy between TLRs and FcgammaRIIa in human dendritic cells","volume":"120","author":"den Dunnen","year":"2012","journal-title":"Blood"},{"key":"B71","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.imlet.2014.07.004","article-title":"Targeting human dendritic cells in situ to improve vaccines","volume":"162","author":"Sehgal","year":"2014","journal-title":"Immunol Lett"},{"key":"B72","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1172\/JCI26032","article-title":"Endocytosis of HIV-1 activates plasmacytoid dendritic cells via toll-like receptor-viral RNA interactions","volume":"115","author":"Beignon","year":"2005","journal-title":"J Clin Invest"},{"key":"B73","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1002\/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q","article-title":"Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells","volume":"31","author":"Jarrossay","year":"2001","journal-title":"Eur J Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/intimm\/dxv062","article-title":"Guanosine and its modified derivatives are endogenous ligands for TLR7","volume":"28","author":"Shibata","year":"2016","journal-title":"Int Immunol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1126\/science.1093620","article-title":"Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8","volume":"303","author":"Heil","year":"2004","journal-title":"Science"},{"key":"B76","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/35047123","article-title":"A toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"key":"B77","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1093\/infdis\/jis384","article-title":"Plasmacytoid dendritic cells (pDCs) from HIV controllers produce interferon-alpha and differentiate into functional killer pDCs under HIV activation","volume":"206","author":"Barblu","year":"2012","journal-title":"J Infect Dis"},{"key":"B78","doi-asserted-by":"publisher","first-page":"248","DOI":"10.4049\/jimmunol.176.1.248","article-title":"Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells","volume":"176","author":"Chaperot","year":"2006","journal-title":"J Immunol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"17453","DOI":"10.1073\/pnas.0707244104","article-title":"HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by toll-like receptor 7-induced IFN-alpha","volume":"104","author":"Hardy","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1126\/science.284.5421.1835","article-title":"The nature of the principal type 1 interferon-producing cells in human blood","volume":"284","author":"Siegal","year":"1999","journal-title":"Science"},{"key":"B81","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type I interferons in infectious disease","volume":"15","author":"McNab","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1073\/pnas.1111573109","article-title":"Role of retroviral restriction factors in the interferon-alpha-mediated suppression of HIV-1 in vivo","volume":"109","author":"Pillai","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B83","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.4049\/jimmunol.179.4.2097","article-title":"NK cell lysis of HIV-1-infected autologous CD4 primary T cells: requirement for IFN-mediated NK activation by plasmacytoid dendritic cells","volume":"179","author":"Tomescu","year":"2007","journal-title":"J Immunol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1097\/QAD.0b013e32835861b0","article-title":"Impact of protective killer inhibitory receptor\/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers","volume":"26","author":"Tomescu","year":"2012","journal-title":"AIDS"},{"key":"B85","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1084\/jem.20130901","article-title":"IL-12 and type I interferon prolong the division of activated CD8 T cells by maintaining high-affinity IL-2 signaling in vivo","volume":"211","author":"Starbeck-Miller","year":"2014","journal-title":"J Exp Med"},{"key":"B86","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nri3865","article-title":"The multifaceted biology of plasmacytoid dendritic cells","volume":"15","author":"Swiecki","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.4049\/jimmunol.178.6.3363","article-title":"Cutting edge: antibody-mediated TLR7-dependent recognition of viral RNA","volume":"178","author":"Wang","year":"2007","journal-title":"J Immunol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1297-9716-43-64","article-title":"Interplay of foot-and-mouth disease virus, antibodies and plasmacytoid dendritic cells: virus opsonization under non-neutralizing conditions results in enhanced interferon-alpha responses","volume":"43","author":"Lannes","year":"2012","journal-title":"Vet Res"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1002\/eji.200635866","article-title":"Plasmacytoid dendritic cell activation by foot-and-mouth disease virus requires immune complexes","volume":"36","author":"Guzylack-Piriou","year":"2006","journal-title":"Eur J Immunol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.1128\/JVI.02495-10","article-title":"Bovine plasmacytoid dendritic cells are the major source of type I interferon in response to foot-and-mouth disease virus in vitro and in vivo","volume":"85","author":"Reid","year":"2011","journal-title":"J Virol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1002\/eji.200525998","article-title":"Fc gamma RII-dependent sensitisation of natural interferon-producing cells for viral infection and interferon-alpha responses","volume":"35","author":"Balmelli","year":"2005","journal-title":"Eur J Immunol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1006\/viro.2000.0627","article-title":"Antibody-dependent induction of type I interferons by poliovirus in human mononuclear blood cells requires the type II Fcgamma receptor (CD32)","volume":"278","author":"Palmer","year":"2000","journal-title":"Virology"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1089\/10799900260475722","article-title":"Immune-specific immunoglobulin G-mediated enhancement of human immunodeficiency virus-induced IFN-alpha production","volume":"22","author":"Green","year":"2002","journal-title":"J Interferon Cytokine Res"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1099\/0022-1317-82-8-1899","article-title":"Human antibodies isolated from plasma by affinity chromatography increase the coxsackievirus B4-induced synthesis of interferon-alpha by human peripheral blood mononuclear cells in vitro","volume":"82","author":"Chehadeh","year":"2001","journal-title":"J Gen Virol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"e7111","DOI":"10.1371\/journal.pone.0007111","article-title":"Plasmacytoid dendritic cells capture and cross-present viral antigens from influenza-virus exposed cells","volume":"4","author":"Lui","year":"2009","journal-title":"PLoS One"},{"key":"B96","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.4049\/jimmunol.1003057","article-title":"Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus","volume":"186","author":"LaMere","year":"2011","journal-title":"J Immunol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"6200","DOI":"10.1073\/pnas.0609174104","article-title":"Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function","volume":"104","author":"James","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B98","doi-asserted-by":"publisher","first-page":"6045","DOI":"10.1073\/pnas.0800159105","article-title":"TRIM21 is an IgG receptor that is structurally, thermodynamically, and kinetically conserved","volume":"105","author":"Keeble","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B99","doi-asserted-by":"publisher","first-page":"19985","DOI":"10.1073\/pnas.1014074107","article-title":"Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)","volume":"107","author":"Mallery","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B100","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/ni.2548","article-title":"Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21","volume":"14","author":"McEwan","year":"2013","journal-title":"Nat Immunol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/imr.12363","article-title":"TRIM21: a cytosolic Fc receptor with broad antibody isotype specificity","volume":"268","author":"Foss","year":"2015","journal-title":"Immunol Rev"},{"key":"B102","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1146\/annurev.immunol.17.1.189","article-title":"Natural killer cells in antiviral defense: function and regulation by innate cytokines","volume":"17","author":"Biron","year":"1999","journal-title":"Annu Rev Immunol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1056\/NEJMoa1608243","article-title":"Effect of HIV antibody VRC01 on viral rebound after treatment interruption","volume":"375","author":"Bar","year":"2016","journal-title":"N Engl J Med"},{"key":"B104","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nm.4268","article-title":"Antibody 10-1074 suppresses viremia in HIV-1-infected individuals","volume":"23","author":"Caskey","year":"2017","journal-title":"Nat Med"},{"key":"B105","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.immuni.2013.08.031","article-title":"Human circulating PD-1+CXCR3\u2212CXCR5+ memory TFH cells are highly functional and correlate with broadly neutralizing HIV antibody responses","volume":"39","author":"Locci","year":"2013","journal-title":"Immunity"},{"key":"B106","doi-asserted-by":"publisher","first-page":"13310","DOI":"10.1128\/JVI.02186-14","article-title":"Early preservation of CXCR5+ PD-1+ helper T cells and B cell activation predict the breadth of neutralizing antibody responses in chronic HIV-1 infection","volume":"88","author":"Cohen","year":"2014","journal-title":"J Virol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/COH.0000000000000053","article-title":"T follicular helper cells and HIV\/SIV-specific antibody responses","volume":"9","author":"Petrovas","year":"2014","journal-title":"Curr Opin HIV AIDS"},{"key":"B108","doi-asserted-by":"publisher","first-page":"e81913","DOI":"10.1371\/journal.pone.0081913","article-title":"Decreased mutation frequencies among immunoglobulin G variable region genes during viremic HIV-1 infection","volume":"9","author":"Bowers","year":"2014","journal-title":"PLoS One"},{"key":"B109","doi-asserted-by":"publisher","first-page":"e1003754","DOI":"10.1371\/journal.ppat.1003754","article-title":"The effects of somatic hypermutation on neutralization and binding in the PGT121 family of broadly neutralizing HIV antibodies","volume":"9","author":"Sok","year":"2013","journal-title":"PLoS Pathog"},{"key":"B110","doi-asserted-by":"publisher","first-page":"6558","DOI":"10.1128\/JVI.75.14.6558-6565.2001","article-title":"Immunoglobulin G3 from polyclonal human immunodeficiency virus (HIV) immune globulin is more potent than other subclasses in neutralizing HIV type 1","volume":"75","author":"Scharf","year":"2001","journal-title":"J Virol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1097\/QAD.0b013e32834b348e","article-title":"Multiple HIV-1-specific IgG3 responses decline during acute HIV-1: implications for detection of incident HIV infection","volume":"25","author":"Yates","year":"2011","journal-title":"AIDS"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1089\/aid.2014.0105","article-title":"Longitudinal analysis of HIV-1-specific antibody responses","volume":"30","author":"Curtis","year":"2014","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B113","doi-asserted-by":"publisher","first-page":"5231","DOI":"10.1128\/JVI.00049-16","article-title":"Detection of broadly neutralizing activity within the first months of HIV-1 infection","volume":"90","author":"Sanchez-Merino","year":"2016","journal-title":"J Virol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/nm.4187","article-title":"Determinants of HIV-1 broadly neutralizing antibody induction","volume":"22","author":"Rusert","year":"2016","journal-title":"Nat Med"},{"key":"B115","doi-asserted-by":"publisher","first-page":"e1005369","DOI":"10.1371\/journal.ppat.1005369","article-title":"Broadly neutralizing antibody responses in a large longitudinal sub-Saharan HIV primary infection cohort","volume":"12","author":"Landais","year":"2016","journal-title":"PLoS Pathog"},{"key":"B116","doi-asserted-by":"publisher","first-page":"10844","DOI":"10.1038\/ncomms10844","article-title":"Elimination of HIV-1-infected cells by broadly neutralizing antibodies","volume":"7","author":"Bruel","year":"2016","journal-title":"Nat Commun"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"Haynes","year":"2012","journal-title":"N Engl J Med"},{"key":"B118","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1172\/JCI75539","article-title":"FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial","volume":"124","author":"Li","year":"2014","journal-title":"J Clin Invest"},{"key":"B119","doi-asserted-by":"publisher","first-page":"6986","DOI":"10.1128\/JVI.00569-12","article-title":"Frequent and strong antibody-mediated natural killer cell activation in response to HIV-1 Env in individuals with chronic HIV-1 infection","volume":"86","author":"Thobakgale","year":"2012","journal-title":"J Virol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"7505","DOI":"10.1073\/pnas.1016048108","article-title":"Immune escape from HIV-specific antibody-dependent cellular cytotoxicity (ADCC) pressure","volume":"108","author":"Chung","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B121","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1002\/eji.201344305","article-title":"Independent evolution of Fc- and Fab-mediated HIV-1-specific antiviral antibody activity following acute infection","volume":"44","author":"Dugast","year":"2014","journal-title":"Eur J Immunol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1097\/QAD.0000000000001221","article-title":"Augmentation of anti-simian immunodeficiency virus activity in CD8+ cells by neutralizing but not nonneutralizing antibodies in the acute phase","volume":"30","author":"Yamamoto","year":"2016","journal-title":"AIDS"},{"key":"B123","doi-asserted-by":"publisher","first-page":"5514","DOI":"10.1128\/JVI.00145-09","article-title":"Polyfunctional CD4+ T-cell induction in neutralizing antibody-triggered control of simian immunodeficiency virus infection","volume":"83","author":"Yamamoto","year":"2009","journal-title":"J Virol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1126\/science.aag0491","article-title":"Antibody-mediated protection against SHIV challenge includes systemic clearance of distal virus","volume":"353","author":"Liu","year":"2016","journal-title":"Science"},{"key":"B125","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3390\/vaccines1030328","article-title":"Isotype diversification of IgG antibodies to HIV Gag proteins as a therapeutic vaccination strategy for HIV infection","volume":"1","author":"French","year":"2013","journal-title":"Vaccines (Basel)"},{"key":"B126","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.cell.2015.10.027","article-title":"Dissecting polyclonal vaccine-induced humoral immunity against HIV using systems serology","volume":"163","author":"Chung","year":"2015","journal-title":"Cell"},{"key":"B127","doi-asserted-by":"publisher","first-page":"e1005817","DOI":"10.1371\/journal.ppat.1005817","article-title":"Antibody-mediated internalization of infectious HIV-1 virions differs among antibody isotypes and subclasses","volume":"12","author":"Tay","year":"2016","journal-title":"PLoS Pathog"},{"key":"B128","doi-asserted-by":"publisher","first-page":"228ra39","DOI":"10.1126\/scitranslmed.3007730","article-title":"Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination","volume":"6","author":"Yates","year":"2014","journal-title":"Sci Transl Med"},{"key":"B129","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/icb.2014.42","article-title":"HIV-specific antibody-dependent phagocytosis matures during HIV infection","volume":"92","author":"Ana-Sosa-Batiz","year":"2014","journal-title":"Immunol Cell Biol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1097\/QAD.0b013e328329f97d","article-title":"Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers","volume":"23","author":"Lambotte","year":"2009","journal-title":"AIDS"},{"key":"B131","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1086\/526786","article-title":"Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy","volume":"197","author":"Pereyra","year":"2008","journal-title":"J Infect Dis"},{"key":"B132","doi-asserted-by":"publisher","first-page":"e74855","DOI":"10.1371\/journal.pone.0074855","article-title":"High antibody-dependent cellular cytotoxicity responses are correlated with strong CD8 T cell viral suppressive activity but not with B57 status in HIV-1 elite controllers","volume":"8","author":"Lambotte","year":"2013","journal-title":"PLoS One"},{"key":"B133","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1089\/vim.2011.0025","article-title":"NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients","volume":"24","author":"Johansson","year":"2011","journal-title":"Viral Immunol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"5468","DOI":"10.1128\/JVI.03403-12","article-title":"Enhanced phagocytic activity of HIV-specific antibodies correlates with natural production of immunoglobulins with skewed affinity for FcgammaR2a and FcgammaR2b","volume":"87","author":"Ackerman","year":"2013","journal-title":"J Virol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1089\/088922201753197105","article-title":"HIV type 1-specific IgG2 antibodies: markers of helper T cell type 1 response and prognostic marker of long-term nonprogression","volume":"17","author":"Ngo-Giang-Huong","year":"2001","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B136","doi-asserted-by":"publisher","first-page":"e1005285","DOI":"10.1371\/journal.ppat.1005285","article-title":"Follicular dendritic cells retain infectious HIV in cycling endosomes","volume":"11","author":"Heesters","year":"2015","journal-title":"PLoS Pathog"},{"key":"B137","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1172\/JCI64314","article-title":"Expansion of HIV-specific T follicular helper cells in chronic HIV infection","volume":"122","author":"Lindqvist","year":"2012","journal-title":"J Clin Invest"},{"key":"B138","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.tim.2016.02.006","article-title":"TFH in HIV latency and as sources of replication-competent virus","volume":"24","author":"Miles","year":"2016","journal-title":"Trends Microbiol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1128\/JVI.02883-15","article-title":"Peripheral T follicular helper cells are the major HIV reservoir within central memory CD4 T cells in peripheral blood from chronically HIV-infected individuals on combination antiretroviral therapy","volume":"90","author":"Pallikkuth","year":"2015","journal-title":"J Virol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1084\/jem.20121932","article-title":"Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production","volume":"210","author":"Perreau","year":"2013","journal-title":"J Exp Med"},{"key":"B141","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1073\/pnas.1318249111","article-title":"Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues","volume":"111","author":"Fletcher","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B142","doi-asserted-by":"publisher","first-page":"e1000107","DOI":"10.1371\/journal.pmed.1000107","article-title":"Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection","volume":"6","author":"Levesque","year":"2009","journal-title":"PLoS Med"},{"key":"B143","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/nm.3109","article-title":"Inadequate T follicular cell help impairs B cell immunity during HIV infection","volume":"19","author":"Cubas","year":"2013","journal-title":"Nat Med"},{"key":"B144","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1182\/blood-2011-12-396648","article-title":"Impaired peripheral blood T-follicular helper cell function in HIV-infected nonresponders to the 2009 H1N1\/09 vaccine","volume":"120","author":"Pallikkuth","year":"2012","journal-title":"Blood"},{"key":"B145","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/COH.0000000000000095","article-title":"The dysfunction of T follicular helper cells","volume":"9","author":"Cubas","year":"2014","journal-title":"Curr Opin HIV AIDS"},{"key":"B146","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s15010-008-7368-9","article-title":"Effect of antiretroviral therapy on apoptosis markers and morphology in peripheral lymph nodes of HIV-infected individuals","volume":"36","author":"Ehrhard","year":"2008","journal-title":"Infection"},{"key":"B147","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1097\/QAD.0b013e328361a427","article-title":"Impairment of B-cell functions during HIV-1 infection","volume":"27","author":"Amu","year":"2013","journal-title":"AIDS"},{"key":"B148","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1084\/jem.20072683","article-title":"Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals","volume":"205","author":"Moir","year":"2008","journal-title":"J Exp Med"},{"key":"B149","doi-asserted-by":"publisher","first-page":"10362","DOI":"10.1073\/pnas.181347898","article-title":"HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals","volume":"98","author":"Moir","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B150","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1084\/jem.20032236","article-title":"Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily","volume":"200","author":"Moir","year":"2004","journal-title":"J Exp Med"},{"key":"B151","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/QAI.0000000000000869","article-title":"Chronic HIV-1 infection induces B-cell dysfunction that is incompletely resolved by long-term antiretroviral therapy","volume":"71","author":"Abudulai","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B152","doi-asserted-by":"publisher","first-page":"8031","DOI":"10.1128\/JVI.00771-12","article-title":"B-lymphocyte dysfunction in chronic HIV-1 infection does not prevent cross-clade neutralization breadth","volume":"86","author":"Boliar","year":"2012","journal-title":"J Virol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1089\/aid.2006.22.640","article-title":"The effects of early antiretroviral therapy and its discontinuation on the HIV-specific antibody response","volume":"22","author":"Killian","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B154","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/j.1468-1293.2006.00406.x","article-title":"Impact of highly active antiretroviral therapy on the maturation of anti-HIV-1 antibodies during primary HIV-1 infection","volume":"7","author":"Adalid-Peralta","year":"2006","journal-title":"HIV Med"},{"key":"B155","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1086\/315774","article-title":"The effect of highly active antiretroviral therapy on binding and neutralizing antibody responses to human immunodeficiency virus type 1 infection","volume":"182","author":"Binley","year":"2000","journal-title":"J Infect Dis"},{"key":"B156","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/00126334-200312010-00002","article-title":"Changes in immunoglobulin isotypes and immunoglobulin G (IgG) subclasses during highly active antiretroviral therapy: anti-p24 IgG1 closely parallels the biphasic decline in plasma viremia","volume":"34","author":"Voltersvik","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B157","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1093\/cid\/ciw365","article-title":"Initiation of antiretroviral therapy during acute HIV-1 infection leads to a high rate of nonreactive HIV serology","volume":"63","author":"de Souza","year":"2016","journal-title":"Clin Infect Dis"},{"key":"B158","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/infdis\/jiu486","article-title":"Antibody-dependent effector functions against HIV decline in subjects receiving antiretroviral therapy","volume":"211","author":"Madhavi","year":"2015","journal-title":"J Infect Dis"},{"key":"B159","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s10875-014-0010-y","article-title":"Highly efficient neutralization by plasma antibodies from human immunodeficiency virus type-1 infected individuals on antiretroviral drug therapy","volume":"34","author":"Andrabi","year":"2014","journal-title":"J Clin Immunol"},{"key":"B160","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1089\/aid.2006.22.908","article-title":"Antiretroviral therapy does not induce HIV type 1-specific neutralizing activity against autologous HIV type 1 isolates","volume":"22","author":"Devito","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B161","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1086\/338099","article-title":"Reconstitution of spontaneous neutralizing antibody response against autologous human immunodeficiency virus during highly active antiretroviral therapy","volume":"185","author":"Kimura","year":"2002","journal-title":"J Infect Dis"},{"key":"B162","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.1128\/JVI.02173-08","article-title":"Preclinical studies of human immunodeficiency virus\/AIDS vaccines: inverse correlation between avidity of anti-Env antibodies and peak postchallenge viremia","volume":"83","author":"Zhao","year":"2009","journal-title":"J Virol"},{"key":"B163","doi-asserted-by":"publisher","first-page":"5981","DOI":"10.1128\/JVI.00320-15","article-title":"What do chaotrope-based avidity assays for antibodies to HIV-1 envelope glycoproteins measure?","volume":"89","author":"Alexander","year":"2015","journal-title":"J Virol"},{"key":"B164","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/QAI.0b013e318120039b","article-title":"Effective highly active antiretroviral therapy in patients with primary HIV-1 infection prevents the evolution of the avidity of HIV-1-specific antibodies","volume":"46","author":"Selleri","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B165","doi-asserted-by":"publisher","first-page":"e55525","DOI":"10.1371\/journal.pone.0055525","article-title":"Effect of natural and ARV-induced viral suppression and viral breakthrough on anti-HIV antibody proportion and avidity in patients with HIV-1 subtype B infection","volume":"8","author":"Wendel","year":"2013","journal-title":"PLoS One"},{"key":"B166","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1089\/AID.2015.0247","article-title":"Short communication: persistence of HIV antibody avidity in the presence of antiretroviral therapy","volume":"32","author":"Curtis","year":"2016","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B167","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1093\/infdis\/jiv110","article-title":"Antibody maturation in women who acquire HIV infection while using antiretroviral preexposure prophylaxis","volume":"212","author":"Laeyendecker","year":"2015","journal-title":"J Infect Dis"},{"key":"B168","doi-asserted-by":"publisher","first-page":"545","DOI":"10.2217\/nnm.16.1","article-title":"Nanodrug formulations to enhance HIV drug exposure in lymphoid tissues and cells: clinical significance and potential impact on treatment and eradication of HIV\/AIDS","volume":"11","author":"Shao","year":"2016","journal-title":"Nanomedicine (Lond)"},{"key":"B169","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1073\/pnas.1520112113","article-title":"CXCL13 is a plasma biomarker of germinal center activity","volume":"113","author":"Havenar-Daughton","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B170","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1365-3083.2012.02764.x","article-title":"Immunization with Leishmania vaccine-alum-BCG and montanide ISA 720 adjuvants induces low-grade type 2 cytokines and high levels of IgG2 subclass antibodies in the vervet monkey (Chlorocebus aethiops) model","volume":"76","author":"Mutiso","year":"2012","journal-title":"Scand J Immunol"},{"key":"B171","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1479-5876-10-4","article-title":"Effects of adjuvants on IgG subclasses elicited by virus-like particles","volume":"10","author":"Visciano","year":"2012","journal-title":"J Transl Med"},{"key":"B172","doi-asserted-by":"publisher","first-page":"e463","DOI":"10.1016\/S2352-3018(16)30055-8","article-title":"Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B\/2A trial","volume":"3","author":"Leth","year":"2016","journal-title":"Lancet HIV"},{"key":"B173","doi-asserted-by":"publisher","first-page":"260","DOI":"10.4161\/hv.4627","article-title":"Influence of IFNgamma co-expression on the safety and antiviral efficacy of recombinant fowlpox virus HIV therapeutic vaccines following interruption of antiretroviral therapy","volume":"3","author":"Emery","year":"2007","journal-title":"Hum Vaccin"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00780\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T07:22:13Z","timestamp":1659165733000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00780\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,4]]},"references-count":173,"alternative-id":["10.3389\/fimmu.2017.00780"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.00780","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,4]]},"article-number":"780"}}